Brief: Burning Rock Reports Third Quarter 2020 Financial Results
Nov 20 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
* SEES FY 2020 REVENUE ABOUT RMB 420 MILLION
* Q3 REVENUE ROSE 19.4 PERCENT TO RMB 123.9 MILLION
* QTRLY LOSS PER SHARE $0.18
Source text for Eikon: ID:nGNXcd2fPV
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer